News & Articles

PWC-Colorcon-TruTag technology coalition prove out the mass digitalization of pharma pills

World’s first portable, low-cost MRI system is a new tool for clinical diagnosis and patient monitoring

Harvard, MIT, and various teaching hospitals team up with industry partners to launch new center for regenerative therapies

Clinical trial will evaluate the safety and immunogenicity of Entervax™

Distinguished speaker Dr. Bruce Levine addresses some of the current healthcare challenges that impact the development of new therapies

Proximity will facilitate local and international sponsor access to Kayentis’ eCOA services for mid- to later-stage clinical trials

Zelluna Immunotherapy presented data on its lead compound ZI-H04 at the Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Lead allosteric PLK1 inhibitor to progress through preclinical and IND enabling studies

Thermo Fisher Scientific's forum focuses on strategies to expedite biotherapeutic development and commercialization

New collaboration to focus on developing potent Affimer-drug conjugates

SelectScience is heading to Chicago, USA, to interview scientists at the forefront of neuroscience research and report on the latest techniques and technologies advancing the field

AstraZeneca BioPharmaceuticals R&D has invested in a LyoConstellationTM S10 freeze dryer intended to help drive research and development of small scale GMP production.

Study done at the University of Cambridge suggests a way to predict prognosis and most effective treatment in cancer

Roche's Tecentriq improves overall survival as a first-line monotherapy in certain people with advanced non-small cell lung cancer

Women with a rare type of ovarian cancer could benefit from a drug that quadruples the likelihood of response compared with standard therapies

Tell us which new products made the most difference to your lab work and you’ll have the chance to win one of four $500 Amazon gift cards

Study aims to develop a rapid point-of-care diagnostic based on multiple biomarkers to detect emergent sepsis

Abbott's new technology is poised to be the first point-of-care blood test for assessing concussions, providing doctors results in 15 minutes

Following last year’s success, we’re hosting our second annual event dedicated to celebrating our Seals of Quality program

Find out how one lab is streamlining the development of lentiviruses and transduction enhancers to treat a range of genetic diseases

Dr. John Connolly, CSO of Tessa Therapeutics, reveals how a new approach to cell-based therapy in cancer could circumvent severe immunotherapy side effects and effectively target aggressive solid tumors

New partnership to advance Nosopharm’s lead candidate to clinical stage

Phase 1 trial scheduled for early 2020 will be first CAR-T cell therapy clinical trial to employ SMARTvector technology